Cost-Effectiveness Analysis of Memantine for Moderate-To-Severe Alzheimer's Disease in the Netherlands

Neuropsychiatric Disease and Treatment - New Zealand
doi 10.2147/ndt.s19239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search